PE20080335A1 - Moleculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapeuticas - Google Patents
Moleculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapeuticasInfo
- Publication number
- PE20080335A1 PE20080335A1 PE2007000739A PE2007000739A PE20080335A1 PE 20080335 A1 PE20080335 A1 PE 20080335A1 PE 2007000739 A PE2007000739 A PE 2007000739A PE 2007000739 A PE2007000739 A PE 2007000739A PE 20080335 A1 PE20080335 A1 PE 20080335A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- cycloalkyl
- synthesis
- therapeutic applications
- molecules containing
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 230000009977 dual effect Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 150000002978 peroxides Chemical class 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE A ES IIa, R6-CHOH- DONDE R Y R' SON CADA UNO H, HALOGENO, CF3, OCF3, -O-CICLOALQUILO C1-C5, ENTRE OTROS; R4 ES H, ALQUILO C1-C5, CICLOALQUILO C3-C5; B1 Y B2 SON N, -CH= CON LA CONDICION QUE B1 Y B2 NO SON IGUALES; R6 ES DE PREFERENCIA 9-FENATRENILO, O UN RESTO HETEROCICLO NITROGENADO; B ES CICLOALQUILO C3-C8 SUSTITUIDO CON UNO O VARIOS HALOGENO, HIDROXILO, ALQUILO C1-C6, ENTRE OTROS; m Y n SON CADA UNO 0-2; R5 ES H, ALQUILO, -C(O)-ALQUILO, -C(O)O-ALQUILO, ALQUILENO C1-C3-CILOALQUILO, ENTRE OTROS; Z1 Y Z2 SON CADA UNO ALQUILENO C1-C4 SATURADO O INSATURADO, REPRESENTANDO Z1+Z2+Ci+Cj: CICLOALQUILO C3-C10, ESTRUCTURA POLICICLICA DE 4-18 ATOMOS DE CARBONO, PUDIENDO REPRESENTAR UNO DE Z1 O Z2 UN ENLACE SENCILLO ENTRE LOS ATOMOS Ci Y Cj; R1 Y R2 SON CADA UNO H, UN GRUPO CAPAZ DE INCREMENTAR LA HIDROSOLUBILIDAD; Rx Y Ry FORMAN JUNTOS UN PEROXIDO CICLICO DE 4-8 ESLABONES Y QUE CONSTA DE 1 O 2 ATOMOS DE OXIGENO ADICIONALES A LA ESTRUCTURA CICLICA, SIENDO Cj UNO DE LOS VERTICES DE ESTE PEROXIDO CICLICO, ENTRE OTROS. UN COMPUESTO PREFERIDO ES N-(7-CLORO-QUINOLIN-4-IL)-CIS-2-[(3,3-DIMETIL-1,2,5-TRIOXA-ESPIRO[5.5]UNDEC-9-ILAMINO)-METIL]-CICLOPENTILAMINA. DICHOS COMPUESTOS TIENEN ACTIVIDAD ANTIPALUDICA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0605235A FR2902100A1 (fr) | 2006-06-13 | 2006-06-13 | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20080335A1 true PE20080335A1 (es) | 2008-05-22 |
Family
ID=37719816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2007000739A PE20080335A1 (es) | 2006-06-13 | 2007-06-12 | Moleculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapeuticas |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20120122923A1 (es) |
| EP (1) | EP2032561A2 (es) |
| JP (1) | JP2009539946A (es) |
| KR (1) | KR20090029208A (es) |
| CN (1) | CN101466706A (es) |
| AP (1) | AP2008004711A0 (es) |
| AR (1) | AR061347A1 (es) |
| AU (1) | AU2007259116A1 (es) |
| BR (1) | BRPI0713739A2 (es) |
| CA (1) | CA2665940A1 (es) |
| CR (1) | CR10469A (es) |
| EA (1) | EA200970002A1 (es) |
| EC (1) | ECSP088958A (es) |
| FR (1) | FR2902100A1 (es) |
| IL (1) | IL195394A0 (es) |
| MA (1) | MA30577B1 (es) |
| MX (1) | MX2008015980A (es) |
| NO (1) | NO20085308L (es) |
| PE (1) | PE20080335A1 (es) |
| TN (1) | TNSN08462A1 (es) |
| TW (1) | TW200817376A (es) |
| UY (1) | UY30413A1 (es) |
| WO (1) | WO2007144487A2 (es) |
| ZA (1) | ZA200810012B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2924343A1 (fr) * | 2007-12-04 | 2009-06-05 | Palumed Sa | Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique. |
| EP2680844B1 (en) | 2011-03-04 | 2016-10-19 | GlaxoSmithKline Intellectual Property Development Limited | Amino-quinolines as kinase inhibitors |
| TWI547494B (zh) | 2011-08-18 | 2016-09-01 | 葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之胺基喹唑啉類 |
| TWI592417B (zh) | 2012-09-13 | 2017-07-21 | 葛蘭素史克智慧財產發展有限公司 | 胺基喹唑啉激酶抑制劑之前藥 |
| AR092530A1 (es) | 2012-09-13 | 2015-04-22 | Glaxosmithkline Llc | Compuesto de amino-quinolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento |
| US9650364B2 (en) | 2013-02-21 | 2017-05-16 | GlaxoSmithKline Intellectual Property Development Limted | Quinazolines as kinase inhibitors |
| CN119822967A (zh) * | 2024-12-24 | 2025-04-15 | 万华化学集团股份有限公司 | 一种hmda的生产方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2133620A1 (en) * | 1993-10-28 | 1995-04-29 | Werner Hofheinz | Aminoquinoline derivatives |
| BR9611727A (pt) * | 1995-11-16 | 1999-05-25 | Hoffmann La Roche | Derivados de quínolina anti-malária |
| HUP0103093A3 (en) * | 1998-04-29 | 2002-03-28 | Smithkline Beecham Plc | Quinolones used as mrs inhibitors and bactericides and process for their preparation |
| FR2807433B1 (fr) * | 2000-04-06 | 2002-09-20 | Centre Nat Rech Scient | Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques |
| US6486199B1 (en) * | 2001-06-21 | 2002-11-26 | Medicines For Malaria Venture Mmv International Centre Cointrin | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| WO2003070244A1 (en) * | 2002-02-22 | 2003-08-28 | Abbott Laboratories | Antagonist of melanin concentrating hormone and their uses |
| SE0202134D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
| US20050256157A1 (en) * | 2002-08-23 | 2005-11-17 | Chiron Corporation | Combination therapy with CHK1 inhibitors |
| US7470709B2 (en) * | 2002-08-23 | 2008-12-30 | Novartis Vaccines And Diagnostics, Inc. | Benzimidazole quinolinones and uses thereof |
| EP1464335A3 (en) * | 2003-03-31 | 2007-05-09 | Taisho Pharmaceutical Co. Ltd. | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist |
| HU227684B1 (en) * | 2003-08-29 | 2011-11-28 | Sanofi Aventis | Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors |
| FR2862304A1 (fr) * | 2003-11-14 | 2005-05-20 | Centre Nat Rech Scient | Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques |
| JP2007517868A (ja) * | 2004-01-07 | 2007-07-05 | アストラゼネカ アクチボラグ | 治療薬ｉ |
| AU2005283085B2 (en) * | 2004-06-18 | 2012-06-21 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| FR2889525A1 (fr) * | 2005-08-04 | 2007-02-09 | Palumed Sa | Nouveaux derives de polyquinoleines et leur utilisation therapeutique. |
-
2006
- 2006-06-13 FR FR0605235A patent/FR2902100A1/fr not_active Withdrawn
-
2007
- 2007-06-08 JP JP2009514836A patent/JP2009539946A/ja not_active Withdrawn
- 2007-06-08 CA CA002665940A patent/CA2665940A1/fr not_active Abandoned
- 2007-06-08 MX MX2008015980A patent/MX2008015980A/es active IP Right Grant
- 2007-06-08 WO PCT/FR2007/000946 patent/WO2007144487A2/fr not_active Ceased
- 2007-06-08 AU AU2007259116A patent/AU2007259116A1/en not_active Abandoned
- 2007-06-08 AP AP2008004711A patent/AP2008004711A0/xx unknown
- 2007-06-08 KR KR1020087030376A patent/KR20090029208A/ko not_active Withdrawn
- 2007-06-08 CN CNA2007800218550A patent/CN101466706A/zh active Pending
- 2007-06-08 ZA ZA200810012A patent/ZA200810012B/xx unknown
- 2007-06-08 EP EP07788851A patent/EP2032561A2/fr not_active Withdrawn
- 2007-06-08 EA EA200970002A patent/EA200970002A1/ru unknown
- 2007-06-08 BR BRPI0713739-7A patent/BRPI0713739A2/pt not_active IP Right Cessation
- 2007-06-12 PE PE2007000739A patent/PE20080335A1/es not_active Application Discontinuation
- 2007-06-12 AR ARP070102553A patent/AR061347A1/es not_active Application Discontinuation
- 2007-06-13 UY UY30413A patent/UY30413A1/es not_active Application Discontinuation
- 2007-06-13 TW TW096121347A patent/TW200817376A/zh unknown
-
2008
- 2008-11-17 TN TNP2008000462A patent/TNSN08462A1/en unknown
- 2008-11-19 IL IL195394A patent/IL195394A0/en unknown
- 2008-11-27 CR CR10469A patent/CR10469A/es not_active Application Discontinuation
- 2008-12-11 EC EC2008008958A patent/ECSP088958A/es unknown
- 2008-12-11 US US12/332,633 patent/US20120122923A1/en not_active Abandoned
- 2008-12-18 NO NO20085308A patent/NO20085308L/no not_active Application Discontinuation
-
2009
- 2009-01-06 MA MA31552A patent/MA30577B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009539946A (ja) | 2009-11-19 |
| KR20090029208A (ko) | 2009-03-20 |
| EA200970002A1 (ru) | 2009-06-30 |
| CA2665940A1 (fr) | 2007-12-21 |
| MA30577B1 (fr) | 2009-07-01 |
| CN101466706A (zh) | 2009-06-24 |
| US20120122923A1 (en) | 2012-05-17 |
| NO20085308L (no) | 2009-03-12 |
| AP2008004711A0 (en) | 2008-12-31 |
| UY30413A1 (es) | 2008-01-31 |
| WO2007144487A2 (fr) | 2007-12-21 |
| BRPI0713739A2 (pt) | 2013-06-18 |
| EP2032561A2 (fr) | 2009-03-11 |
| TW200817376A (en) | 2008-04-16 |
| MX2008015980A (es) | 2009-03-26 |
| AR061347A1 (es) | 2008-08-20 |
| AU2007259116A1 (en) | 2007-12-21 |
| WO2007144487A3 (fr) | 2008-02-07 |
| ECSP088958A (es) | 2009-01-30 |
| CR10469A (es) | 2009-02-26 |
| AU2007259116A8 (en) | 2009-04-30 |
| FR2902100A1 (fr) | 2007-12-14 |
| TNSN08462A1 (en) | 2010-04-14 |
| IL195394A0 (en) | 2009-08-03 |
| ZA200810012B (en) | 2010-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20080335A1 (es) | Moleculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapeuticas | |
| PE20221253A1 (es) | Inhibidores de pequenas moleculas de mutante g12c de kras | |
| UY30603A1 (es) | Derivados de 2-aril-6-fenil-imidazo[1, 2-a]piridinas, su preparacion y su aplicacion en terapéutica | |
| ECSP045369A (es) | Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica | |
| PE20050431A1 (es) | Peptidos macrociclicos activos contra el virus de la hepatitis c | |
| PE20040373A1 (es) | Composiciones herbicidas que comprenden derivados de isoxazolina | |
| AR055774A1 (es) | Fenilacetamidas apropiadas como inhibidores de proteina quinasa | |
| AR093403A1 (es) | COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA UTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL23 Y/O INFa | |
| BRPI0612888B8 (pt) | anilino-piridinotriazinas cíclicas como inibidoras de gsk-3, seus usos e composição farmacêutica, intermediário, seu uso e composição farmacêutica | |
| AR068538A1 (es) | Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido | |
| AR119494A1 (es) | DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS | |
| ECSP088253A (es) | Derivados de azol y tiazol y sus usos | |
| DOP2007000022A (es) | Derivados de n-heteroaril-carboxamidas tricíclicas que contienen un resto bencimidazol, su preparación y su aplicación en terapéutica | |
| CU23926B1 (es) | Derivado de oxopirazina y herbicida | |
| DOP2010000046A (es) | Compuestos de biciclolactama sustituida | |
| AR061642A1 (es) | Derivados de ureas de tropano, su preparacion y su aplicacion en terapeu-tica, procesos de obtencion y composiciones farmaceuticas | |
| NI201000130A (es) | Derivados de urea de tetrahidroquinoxalina, su preparación y su aplicación en terapéutica. | |
| AR047817A1 (es) | Derivados de aril- y heteroarilpiperidincarboxilatos, su preparacion y su aplicacion en terapeutica | |
| UY32801A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| PA8776401A1 (es) | Nuevos compuestos hetericiclicos nitrogenados, su preparación y su utilización como medicamentos antibacterianos | |
| CO5680412A2 (es) | Agonistas del receptor adrenergico etilamino beta 2 sustituido con amino | |
| CO6170405A2 (es) | Composicion plaguicida que comprende fluopicolida y un compuesto insecticida | |
| DE602006006850D1 (de) | Als modulatoren von dopamin-d3-rezeptoren geeignete azabicyclo-(3,1,0)-hexan-derivate | |
| CO6251235A2 (es) | Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica | |
| AR057408A1 (es) | Agonistas del receptor de niacina composiciones que contienen tales compuestos y procedimientos para tratamiento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |